196 related articles for article (PubMed ID: 15727054)
1. Toxicogenomics: regulatory perspective on current position.
Battershill JM
Hum Exp Toxicol; 2005 Jan; 24(1):35-40. PubMed ID: 15727054
[TBL] [Abstract][Full Text] [Related]
2. Application of toxicogenomics in hepatic systems toxicology for risk assessment: acetaminophen as a case study.
Kienhuis AS; Bessems JG; Pennings JL; Driessen M; Luijten M; van Delft JH; Peijnenburg AA; van der Ven LT
Toxicol Appl Pharmacol; 2011 Jan; 250(2):96-107. PubMed ID: 20970440
[TBL] [Abstract][Full Text] [Related]
3. Utilizing toxicogenomic data to understand chemical mechanism of action in risk assessment.
Wilson VS; Keshava N; Hester S; Segal D; Chiu W; Thompson CM; Euling SY
Toxicol Appl Pharmacol; 2013 Sep; 271(3):299-308. PubMed ID: 21295051
[TBL] [Abstract][Full Text] [Related]
4. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
[TBL] [Abstract][Full Text] [Related]
5. Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water.
Moffat I; Chepelev N; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Williams A; Halappanavar S; Malik A; Luijten M; Aubrecht J; Hyduke DR; Fornace AJ; Swartz CD; Recio L; Yauk CL
Crit Rev Toxicol; 2015 Jan; 45(1):1-43. PubMed ID: 25605026
[TBL] [Abstract][Full Text] [Related]
6. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
Heijne WH; Kienhuis AS; van Ommen B; Stierum RH; Groten JP
Expert Rev Proteomics; 2005 Oct; 2(5):767-80. PubMed ID: 16209655
[TBL] [Abstract][Full Text] [Related]
7. Toxicogenomic profiling of chemically exposed humans in risk assessment.
McHale CM; Zhang L; Hubbard AE; Smith MT
Mutat Res; 2010 Dec; 705(3):172-83. PubMed ID: 20382258
[TBL] [Abstract][Full Text] [Related]
8. Integrating toxicogenomics into human health risk assessment: lessons learned from the benzo[a]pyrene case study.
Chepelev NL; Moffat ID; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Malik AI; Halappanavar S; Williams A; Yauk CL
Crit Rev Toxicol; 2015 Jan; 45(1):44-52. PubMed ID: 25605027
[TBL] [Abstract][Full Text] [Related]
9. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
Youns M; Hoheisel JD; Efferth T
Planta Med; 2010 Dec; 76(17):2019-25. PubMed ID: 20957595
[TBL] [Abstract][Full Text] [Related]
10. Immunotoxicogenomics: the potential of genomics technology in the immunotoxicity risk assessment process.
Luebke RW; Holsapple MP; Ladics GS; Luster MI; Selgrade M; Smialowicz RJ; Woolhiser MR; Germolec DR
Toxicol Sci; 2006 Nov; 94(1):22-7. PubMed ID: 16882865
[TBL] [Abstract][Full Text] [Related]
11. The Japanese toxicogenomics project: application of toxicogenomics.
Uehara T; Ono A; Maruyama T; Kato I; Yamada H; Ohno Y; Urushidani T
Mol Nutr Food Res; 2010 Feb; 54(2):218-27. PubMed ID: 20041446
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profile analysis: an emerging approach to investigate mechanisms of genotoxicity.
Aubrecht J; Caba E
Pharmacogenomics; 2005 Jun; 6(4):419-28. PubMed ID: 16004560
[TBL] [Abstract][Full Text] [Related]
13. Toxicogenomics - What added Value Do These Approaches Provide for Carcinogen Risk Assessment?
Schmitz-Spanke S
Environ Res; 2019 Jun; 173():157-164. PubMed ID: 30909101
[TBL] [Abstract][Full Text] [Related]
14. How can toxicogenomics inform risk assessment?
Oberemm A; Onyon L; Gundert-Remy U
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):592-8. PubMed ID: 15990130
[TBL] [Abstract][Full Text] [Related]
15. Toxicogenomics in Environmental Science.
Brinke A; Buchinger S
Adv Biochem Eng Biotechnol; 2017; 157():159-186. PubMed ID: 27864593
[TBL] [Abstract][Full Text] [Related]
16. Contribution of new technologies to characterization and prediction of adverse effects.
Rouquié D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C
Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431
[TBL] [Abstract][Full Text] [Related]
17. Toxicogenomics Approaches to Address Toxicity and Carcinogenicity in the Liver.
Pandiri AR; Auerbach SS; Stevens JL; Blomme EAG
Toxicol Pathol; 2023 Oct; 51(7-8):470-481. PubMed ID: 38288963
[TBL] [Abstract][Full Text] [Related]
18. Toxicogenomics: A 2020 Vision.
Liu Z; Huang R; Roberts R; Tong W
Trends Pharmacol Sci; 2019 Feb; 40(2):92-103. PubMed ID: 30594306
[TBL] [Abstract][Full Text] [Related]
19. Application of toxicogenomics to genetic toxicology risk assessment.
Thybaud V; Le Fevre AC; Boitier E
Environ Mol Mutagen; 2007 Jun; 48(5):369-79. PubMed ID: 17567850
[TBL] [Abstract][Full Text] [Related]
20. The use of evidence from high-throughput screening and transcriptomic data in human health risk assessments.
Mezencev R; Subramaniam R
Toxicol Appl Pharmacol; 2019 Oct; 380():114706. PubMed ID: 31400414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
